SAGE-217 in major depressive disorder: A multicenter, randomized, double-blind, Phase 2 placebo-controlled trial

作者：Handan Gunduz-Bruce, Christopher Silber, Anthony J. Rothschild, R. Riesenberg, Abdul J. Sankoh, H. Li, E. Li, Charles F. Zorumski, David R. Rubinow, Steven M. Paul, J. Jonas, J. Doherty, Stephen Kanes · 发表于：European Neuropsychopharmacology · 年份：2019 · DOI：10.1016/j.euroneuro.2018.11.1036 · 被引用次数：6 · 研究领域：Pharmaceutical studies and practices